✦ LIBER ✦

Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis

✍ Scribed by Per Soelberg Sorensen; Christian Ross; Katja Maria Clemmesen; Klaus Bendtzen; Jette Lautrup Frederiksen; Kai Jensen; Ole Kristensen; Thor Petersen; Soren Rasmussen; Mads Ravnborg; Egon Stenager; Nils Koch-Henriksen

Book ID: 117284731
Publisher: The Lancet
Year: 2003
Tongue: English
Weight: 129 KB
Volume: 362
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(03)14541-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical significance of antibodies to i

Clinical significance of antibodies to interferon beta therapy in patients with relapsing–remitting multiple sclerosis

✍ Klaus Bendtzen 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Managing side effects of interferon-beta

Managing side effects of interferon-beta in patients with relapsing-remitting multiple sclerosis

✍ Frederick E. Munschauer III; Revere Philip Kinkel 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 808 KB

Study of binding and neutralising antibo

Study of binding and neutralising antibodies to interferon-β in two groups of relapsing-remitting multiple sclerosis patients

✍ Oscar Fernández; Cristobalina Mayorga; Gloria Luque; Miguel Guerrero; Rocío Guer 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 259 KB

Predictive factors of neutralizing antib

Predictive factors of neutralizing antibodies development in relapsing-remitting multiple sclerosis patients on interferon Beta-1b therapy

✍ R. Lanzillo; G. Orefice; A. Prinster; G. Ventrella; R. Liuzzi; V. Scarano; C. Fl 📂 Article 📅 2011 🏛 Springer Milan 🌐 English ⚖ 174 KB

A phase I clinical trial of human recomb

A phase I clinical trial of human recombinant beta interferon in relapsing-remitting multiple sclerosis

✍ J.I. Greenstein; R.L. Knobler; K.P. Johnson; S.G. Marcus; H.S. Panitch; F.D. Lub 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Interferon beta inhibits the Th17 cell-m

Interferon beta inhibits the Th17 cell-mediated autoimmune response in patients with relapsing–remitting multiple sclerosis

✍ Xin Zhang; Silva Markovic-Plese 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 214 KB